Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 28;23(3):1542.
doi: 10.3390/ijms23031542.

Molecular Mechanisms of Kidney Injury and Repair

Affiliations
Review

Molecular Mechanisms of Kidney Injury and Repair

Sandra Rayego-Mateos et al. Int J Mol Sci. .

Abstract

Chronic kidney disease (CKD) will become the fifth global cause of death by 2040, thus emphasizing the need to better understand the molecular mechanisms of damage and regeneration in the kidney. CKD predisposes to acute kidney injury (AKI) which, in turn, promotes CKD progression. This implies that CKD or the AKI-to-CKD transition are associated with dysfunctional kidney repair mechanisms. Current therapeutic options slow CKD progression but fail to treat or accelerate recovery from AKI and are unable to promote kidney regeneration. Unraveling the cellular and molecular mechanisms involved in kidney injury and repair, including the failure of this process, may provide novel biomarkers and therapeutic tools. We now review the contribution of different molecular and cellular events to the AKI-to-CKD transition, focusing on the role of macrophages in kidney injury, the different forms of regulated cell death and necroinflammation, cellular senescence and the senescence-associated secretory phenotype (SAPS), polyploidization, and podocyte injury and activation of parietal epithelial cells. Next, we discuss key contributors to repair of kidney injury and opportunities for their therapeutic manipulation, with a focus on resident renal progenitor cells, stem cells and their reparative secretome, certain macrophage subphenotypes within the M2 phenotype and senescent cell clearance.

Keywords: acute kidney injury; cell death; chronic kidney disease; kidney; molecular mechanisms; regeneration; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Mechanisms of kidney injury and repair.
Figure 2
Figure 2
Principal hallmarks of senescent cells. Many different stimuli may cause a DNA damage in the cell and activate the DNA-Damage Response (DDR), which may produce the expression of the Cell-Cycle Arrest (CCA) molecules. Prolonged activation of DDR and CCA proteins produce cellular senescence and the release of the Senescent-Associated Secretory Phenotype (SASP), enriched in different proinflammatory, profibrotic and growth factors that are regulated by NF-κB pathway activation and may cause activation of cellular senescence in a paracrine manner, inflammaging and fibrosis in the kidney, and other tissues.
Figure 3
Figure 3
Glomerulonephritis characterized by a fibrous structure formation (crescent) in renal corpuscle. Glomerular PECs (cytokeratin+) are the main actors, infiltrating cells such as macrophages (CD68+) in crescent formation during rapid progressive glomerulonephritis/crescentic glomerulonephritis (RPGN/CGN). Activated PECs (CD44+/cytokeratin-) invade the glomerular urinary space and obstruct the urinary space. PEC “activation” implies a phenotypic change that promotes their abnormal proliferation and their migration towards the urinary space of renal corpuscles.

References

    1. Ortiz A., Roger M., Jiménez V.M., Perez J.C.R., Furlano M., Atxer L.S., Zurro D.G., Casabona C.M.R., Zurro D.G., Gómez C.G., et al. RICORS2040: The need for collaborative research in chronic kidney disease. Clin. Kidney J. 2021 doi: 10.1093/ckj/sfab170. - DOI
    1. Chawla L.S., Eggers P.W., Star R.A., Kimmel P.L. Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes. N. Engl. J. Med. 2014;371:58–66. doi: 10.1056/NEJMra1214243. - DOI - PMC - PubMed
    1. Ruiz-Ortega M., Rayego-Mateos S., Lamas S., Ortiz A., Rodrigues-Diez R.R. Targeting the progression of chronic kidney disease. Nat. Rev. Nephrol. 2020;16:269–288. doi: 10.1038/s41581-019-0248-y. - DOI - PubMed
    1. Ucero A.C., Benito-Martin A., Izquierdo M.C., Sanchez-Niño M.D., Sanz A.B., Ramos A.M., Berzal S., Ruiz-Ortega M., Egido J., Ortiz A. Unilateral ureteral obstruction: Beyond obstruction. Int. Urol. Nephrol. 2014;46:765–776. doi: 10.1007/s11255-013-0520-1. - DOI - PubMed
    1. Linkermann A., Stockwell B.R., Krautwald S., Anders H.-J. Regulated cell death and inflammation: An auto-amplification loop causes organ failure. Nat. Rev. Immunol. 2014;14:759–767. doi: 10.1038/nri3743. - DOI - PubMed